Growth hormone medicine change survey for kids
Part of Bones, joints & muscles, Brain & nervous system, Hormones & metabolism clinical trials.
This survey asks children and teens currently using daily growth hormone shots if they would like to switch to a longer-acting medicine that requires fewer injections. Your answers will help doctors understand patient preferences.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are currently receiving growth hormone treatment for certain medical conditions approved in Belgium or Luxembourg.
- You are between 0 and 18 years old.
- You are part of the BELGROW patient registry.
- You or your parent/guardian give permission to take part (written or electronic consent).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows adults who had growth hormone deficiency as children and are now part of a research registry. It aims to understand their health outcomes as they transition into adulthood.
This trial studies how different types of growth hormone treatment affect growth and metabolism in children with growth hormone deficiency. It helps compare standard treatment with a long-acting type and looks at growth and metabolic changes.
This study looks at how the body’s growth signals (growth hormone and related proteins) work in children. It may help researchers understand growth differences in kids who are healthy or have certain growth-related conditions.
This study tracks the safety of lonapegsomatropin in children being treated for growth hormone deficiency (GHD). It’s meant to check for side effects and make sure the medicine continues to be safe in real-world use.
This study follows children who are short for their age and checks how safe and effective growth hormone is over the long term. It may help families understand expected benefits and side effects for their specific growth-related condition.
This study tests a new growth hormone injection (GB08) for children who are not growing well because of a condition called growth hormone deficiency. It aims to see if the medicine is safe and helps them grow taller.
Hear when a new Growth Hormone Deficiency trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.